1. People's Republic of China Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Zhejiang Jolly Pharmaceutical Co.,LTD

Zhejiang Jolly Pharmaceutical Co.,LTD

300181.SZ
Zhejiang Jolly Pharmaceutical Co.,LTDCN flagShenzhen Stock Exchange
14.37
CNY
+0.20
- -
9.86BMarket Cap

Total Valuation

Zhejiang Jolly Pharmaceutical Co.,LTD carries a market capitalization of 9.86B, placing it among publicly traded companies globally. Its enterprise value stands at 12.13B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap9.86B
Enterprise Value12.13B

Share Statistics

Zhejiang Jolly Pharmaceutical Co.,LTD currently has 701.39M shares outstanding.

Shares Outstanding701.39M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Zhejiang Jolly Pharmaceutical Co.,LTD trades at a trailing price-to-earnings ratio of 20.77. The price-to-sales ratio is 4.42, and the price-to-book ratio stands at 8.07.

PE Ratio20.77
PS Ratio4.42
PB Ratio8.07
P/TBV Ratio4.22
P/FCF Ratio38.58
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Zhejiang Jolly Pharmaceutical Co.,LTD trades at an EV/EBITDA multiple of 16.53 and an EV/FCF ratio of 37.32. The EV/Sales ratio of 4.41 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 16.53 provides insight into valuation relative to core operating earnings.

EV / Sales4.41
EV / EBITDA16.53
EV / EBIT16.53
EV / FCF37.32

Financial Position

Zhejiang Jolly Pharmaceutical Co.,LTD maintains a current ratio of 1.82, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 20.69, indicating elevated leverage, while an interest coverage ratio of 61.93 demonstrates strong ability to service its debt obligations.

Current Ratio1.82
Quick Ratio0.58
Debt / Equity20.69
Debt / EBITDA0.88
Interest Coverage61.93

Financial Efficiency

Zhejiang Jolly Pharmaceutical Co.,LTD posts a return on equity of 40.54 and a return on invested capital of 18.04.

Return on Equity (ROE)40.54
Return on Assets (ROA)13.78
Return on Invested Capital (ROIC)18.04
Return on Capital Employed (ROCE)30.02
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover2.16

Taxes

Over the trailing twelve months, Zhejiang Jolly Pharmaceutical Co.,LTD has paid 105.02M in income taxes, reflecting an effective tax rate of 15.00.

Income Tax105.02M
Effective Tax Rate15.00

Stock Price Statistics

Zhejiang Jolly Pharmaceutical Co.,LTD's stock has declined approximately -23.56383% over the past 52 weeks. The 50-day moving average sits at 14.19, while the 200-day moving average is 16.25.

Beta (5Y)N/A
52-Week Price Change-23.56383%
50-Day Moving Average14.19
200-Day Moving Average16.25
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Zhejiang Jolly Pharmaceutical Co.,LTD generated 2.75B in revenue and converted that into 585.22M in net income, yielding earnings per share of 0.85. EBITDA reached 734.12M, while operating income came in at 734.12M.

Revenue2.75B
Gross Profit1.68B
Operating Income734.12M
Pretax Income700.32M
Net Income585.22M
EBITDA734.12M
EBIT734.12M
Earnings Per Share (EPS)0.85

Balance Sheet

Zhejiang Jolly Pharmaceutical Co.,LTD holds 731.33M in cash and equivalents against 642.71M in total debt, resulting in a net debt position of -109.48M. Total book value stands at 1.51B, with working capital of 1.03B providing operational flexibility.

Cash & Cash Equivalents731.33M
Total Debt642.71M
Net Debt-109.48M
Equity (Book Value)1.51B
Book Value Per Share2.15
Working Capital1.03B

Cash Flow

After subtracting -315.07M in capital expenditures, free cash flow totaled -315.07M - equivalent to -0.45 per share.

Operating Cash FlowN/A
Capital Expenditures-315.07M
Free Cash Flow-315.07M
FCF Per Share-0.45

Margins

Zhejiang Jolly Pharmaceutical Co.,LTD operates with a gross margin of 61.28, reflecting its pricing power and cost economics. The operating margin of 26.70 and net profit margin of 21.29 provide insight into operational efficiency.

Gross Margin61.28
Operating Margin26.70
Pretax Margin25.47
Profit Margin21.29
EBITDA Margin26.70

Dividends & Yields

The company's payout ratio of 71.55 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share0.62
Dividend YieldN/A
Payout Ratio71.55
Shareholder Yield1.81
FCF Yield2.59

Stock Splits

Zhejiang Jolly Pharmaceutical Co.,LTD's most recent stock split took place on May 20, 2015 with a 10:17 split ratio.

Last Split Date5/20/2015
Split Ratio10:17

Scores

Zhejiang Jolly Pharmaceutical Co.,LTD posts an Altman Z-Score of 6.61, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score6.61